Abstract

Oligomers of β-amyloid 42 (Aβ42), rather than fibrils, drive the pathogenesis of Alzheimer's disease (AD). In particular, toxic oligomeric species called protofibrils (PFs) have attracted significant attention. Herein, we report RNA aptamers with higher affinity toward PFs derived from a toxic Aβ42 dimer than toward fibrils produced from WT Aβ42 or from a toxic, conformationally constrained Aβ42 variant, E22P-Aβ42. We obtained these RNA aptamers by using the preincubated dimer model of E22P-Aβ42, which dimerized via a linker located at Val-40, as the target of in vitro selection. This dimer formed PFs during incubation. Several physicochemical characteristics of an identified aptamer, E22P-AbD43, suggested that preferential affinity of this aptamer toward PFs is due to its higher affinity for the toxic dimer unit (KD = 20 ± 6.0 nm) of Aβ42 than for less-toxic Aβ40 aggregates. Comparison of CD data from the full-length and random regions of E22P-AbD43 suggested that the preferential binding of E22P-AbD43 toward the dimer might be related to the formation of a G-quadruplex structure. E22P-AbD43 significantly inhibited the nucleation phase of the dimer and its associated neurotoxicity in SH-SY5Y human neuroblastoma cells. Of note, E22P-AbD43 also significantly protected against the neurotoxicity of WT Aβ42 and E22P-Aβ42. Furthermore, in an AD mouse model, E22P-AbD43 preferentially recognized diffuse aggregates, which likely originated from PFs or higher-order oligomers with curvilinear structures, compared with senile plaques formed from fibrils. We conclude that the E22P-AbD43 aptamer is a promising research and diagnostic tool for further studies of AD etiology.

Highlights

  • Oligomers of ␤-amyloid 42 (A␤42), rather than fibrils, drive the pathogenesis of Alzheimer’s disease (AD)

  • The current report describes a comprehensive study on the development of RNA aptamers with potent affinity for the toxic dimer model of A␤42 (E22P–V40DAP–A␤42 dimer), and we discuss their application to therapeutics and diagnostics based on experiments using an AD mouse brain

  • Given unsuccessful enrichment in the two trials stated above using the A␤-immobilized column, it should be noted that the use of membrane filtering (Fig. S2) may be more effective for the selection of aptamers targeting oligomeric assemblies including ordered structures such as PFs

Read more

Summary

ARTICLE cro

An RNA aptamer with potent affinity for a toxic dimer of amyloid ␤42 has potential utility for histochemical studies of Alzheimer’s disease. We report RNA aptamers with higher affinity toward PFs derived from a toxic A␤42 dimer than toward fibrils produced from WT A␤42 or from a toxic, conformationally constrained A␤42 variant, E22P–A␤42 We obtained these RNA aptamers by using the preincubated dimer model of E22P–A␤42, which dimerized via a linker located at Val-40, as the target of in vitro selection. We recently developed a covalently linked dimer model of E22P–A␤42 using an L,L-2,6-diaminopimelic acid (DAP) linker at Val-40 in the C-terminal hydrophobic core (Fig. 1A, E22P–V40DAP–A␤42 dimer), which plays an important role in the formation of toxic oligomers This dimer model produced quasistable PFs, which were toxic oligomers, and had a neurotoxic effect on SH-SY5Y human neuroblastoma cells following incubation [20]. The current report describes a comprehensive study on the development of RNA aptamers with potent affinity for the toxic dimer model of A␤42 (E22P–V40DAP–A␤42 dimer), and we discuss their application to therapeutics and diagnostics based on experiments using an AD mouse brain

Results
Discussion
Preparation of PFs
Preparation of the initial RNA pool
SELEX for RNA aptamers using PFs as targets
Fluorescence polarization
Sequencing and prediction of secondary structure of the RNAs
CD spectropolarimetry
MTT assay
Histochemical staining
Statistical analysis
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.